1. Home
  2. HSCS vs ARTL Comparison

HSCS vs ARTL Comparison

Compare HSCS & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSCS
  • ARTL
  • Stock Information
  • Founded
  • HSCS 2007
  • ARTL 2011
  • Country
  • HSCS United States
  • ARTL United States
  • Employees
  • HSCS N/A
  • ARTL N/A
  • Industry
  • HSCS Medical Specialities
  • ARTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • HSCS Health Care
  • ARTL Health Care
  • Exchange
  • HSCS Nasdaq
  • ARTL Nasdaq
  • Market Cap
  • HSCS 3.7M
  • ARTL 3.1M
  • IPO Year
  • HSCS 2022
  • ARTL N/A
  • Fundamental
  • Price
  • HSCS $3.87
  • ARTL $6.86
  • Analyst Decision
  • HSCS Strong Buy
  • ARTL Buy
  • Analyst Count
  • HSCS 2
  • ARTL 2
  • Target Price
  • HSCS $13.00
  • ARTL $30.00
  • AVG Volume (30 Days)
  • HSCS 68.9K
  • ARTL 14.8K
  • Earning Date
  • HSCS 07-28-2025
  • ARTL 08-12-2025
  • Dividend Yield
  • HSCS N/A
  • ARTL N/A
  • EPS Growth
  • HSCS N/A
  • ARTL N/A
  • EPS
  • HSCS N/A
  • ARTL N/A
  • Revenue
  • HSCS N/A
  • ARTL N/A
  • Revenue This Year
  • HSCS N/A
  • ARTL N/A
  • Revenue Next Year
  • HSCS N/A
  • ARTL N/A
  • P/E Ratio
  • HSCS N/A
  • ARTL N/A
  • Revenue Growth
  • HSCS 261.17
  • ARTL N/A
  • 52 Week Low
  • HSCS $2.36
  • ARTL $4.92
  • 52 Week High
  • HSCS $5.77
  • ARTL $9.30
  • Technical
  • Relative Strength Index (RSI)
  • HSCS 52.06
  • ARTL 59.07
  • Support Level
  • HSCS $3.66
  • ARTL $5.76
  • Resistance Level
  • HSCS $4.03
  • ARTL $6.15
  • Average True Range (ATR)
  • HSCS 0.30
  • ARTL 0.46
  • MACD
  • HSCS 0.01
  • ARTL -0.04
  • Stochastic Oscillator
  • HSCS 41.11
  • ARTL 69.53

About HSCS Heart Test Laboratories Inc.

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Share on Social Networks: